VRTX Competitors
Vertex Pharmaceuticals Incorporated
$498.50
+$13.28(+2.74%)
51
Overall
60
Value
30
Tech
63
Quality
Market Cap
$122.98B
Volume
2.06M
52W Range
$402.58 - $560.25
Target Price
$572.86
VRTX competitors: GILD, ABBV, JNJ, BMY, MRK. Vertex Pharmaceuticals Incorporated is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
VRTX Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| GILD Gilead Sciences, Inc. | $153.54 | $190.38B | $-0.47 | 2.12% | 73 |
| ABBV AbbVie Inc. | $283.48 | $500.94B | $13.94 | 2.41% | 70 |
| JNJ Johnson & Johnson | $253.91 | $599.12B | $11.09 | 2.08% | 56 |
| BMY Bristol-Myers Squibb Company | $59.28 | $121.09B | $6.80 | 3.19% | 63 |
| MRK Merck & Co., Inc. | $147.37 | $350.29B | $2.66 | 2.31% | 67 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VRTX | $498.50 | +2.7% | 2.06M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Vertex Pharmaceuticals Incorporated Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW